Generics poured out before ‘ezetimibe’ patent expiration of KRW 60 billion

Facing the patent expiration of the ezetimibe drug(product name: Ezetrol), a hyperlipidemia treatment, a number of ezetimibe+statin complexes emerged and foretold fierce competition.

The substance patent expiration of the ezetimibe drug is the 29^th of April. The most well-known drug, Vytorin, a ezetimibe+simvastatin complex, is one of the largest products leading the market, recording KRW 66 b...